Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5414880

C[C@H](C(=O)O)c1ccoc1N.O=C(O)C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 9/20 0.37
PTGS1 P23219 6/20 0.36
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
AKR1C3 P42330 3/20 0.33
AKR1C2 P52895 2/20 0.33
CXCL8 P10145 2/20 0.33
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
MMP8 P22894 1/20 0.33
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
MMP14 P50281 1/20 0.33
MMP16 P51512 1/20 0.33
LMNA P02545 2/20 0.33
CYP2C9 P11712 2/20 0.33
CXCR1 P25024 2/20 0.33
CXCR2 P25025 2/20 0.33
CPA1 P15085 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4809657 0.90 PTGS2 (0.40) PTGS2PTGS1CYP1A2CYP2D6AKR1C3
SCHEMBL4810662 0.90 PTGS2 (0.40) PTGS2PTGS1CYP1A2CYP2D6AKR1C3
Trifluoroacetic Acid SCHEMBL27369756 0.71 PTGS2 (0.60) PTGS2PTGS1CYP1A2CYP2D6AKR1C3
SCHEMBL194437 0.68 AKR1C3 (0.52) PTGS2PTGS1AKR1C3AKR1C2CXCL8
SCHEMBL30428161 0.68 AKR1C3 (0.52) PTGS2PTGS1AKR1C3AKR1C2CXCL8
SCHEMBL18610686 0.67
SCHEMBL18640605 0.67 PTGS2 (0.37) PTGS2PTGS1AKR1C3AKR1C2CXCL8
SCHEMBL7250159 0.66 CXCL8 (0.41) PTGS2PTGS1CYP1A2CXCL8MMP1
SCHEMBL18640601 0.66 PTGS2 (0.39) PTGS2PTGS1AKR1C3AKR1C2CXCL8
SCHEMBL5215577 0.65 PTGS2 (0.52) PTGS2PTGS1CYP1A2CYP2D6AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7303750-B2 Methods to improve immunogenicity of antigens and specificity of antibodies SEREX, INC. (US) 2007-12-04 US disclosed
US-20030113339-A1 Methods to improve immunogenicity of antigens and specificity of antibodies SEREX, INC. 2003-06-19 US disclosed
US-20030095976-A1 Immunizing with the hapten linked to a carrier protein and boosting the immunization with the hapten conjugated to the carrier by a different linker, especially a 2-amino-3-furylpropionyl linkage SEREX, INC. 2003-05-22 US disclosed
US-20030086939-A1 Methods to improve immunogenicity of antigens and specificity of antibodies SEREX, INC. 2003-05-08 US disclosed
US-20030077287-A1 Methods to improve immunogenicity of antigens and specificity of antibodies SEREX, INC. 2003-04-24 US disclosed
US-6455047-B1 IMPROVING SPECIFIC IMMUNE RESPONSES TO SMALL IMMUNOGENS, HAPTENS, HAS BEEN DEVELOPED BY CHANGING THE LINKAGE BETWEEN THE HAPTEN AND CARRIER BEING USED FOR IMMUNIZATION. HIGH AFFINITY ANTIBODIES TO THE HAPTEN COTININE HAVE BEEN PRODUCED SEREX, INC. 2002-09-24 US disclosed
EP-1015028-A2 METHODS TO IMPROVE IMMUNOGENICITY OF ANTIGENS AND SPECIFICITY OF ANTIBODIES SEREX, INC. (US) 2000-07-05 EP disclosed
WO-1999013907-A9 METHODS TO IMPROVE IMMUNOGENICITY OF ANTIGENS AND SPECIFICITY OF ANTIBODIES SEREX INC (US) 1999-09-10 WO disclosed
WO-1999013907-A2 METHODS TO IMPROVE IMMUNOGENICITY OF ANTIGENS AND SPECIFICITY OF ANTIBODIES SEREX, INC. (US) 1999-03-25 WO disclosed